Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Prolapse 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Metrorrhagia 1Fallopian Tube Neoplasms 1Endometriosis 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 18Paclitaxel 17Bevacizumab 17olaparib 8Specimen Handling 7liposomal doxorubicin 6pembrolizumab 5Taxes 5Biopsy 5cemiplimab 4Magnetic Resonance Spectroscopy 4sarilumab 3niraparib 3mirvetuximab soravtansine 3Topotecan 3Standard of Care 3Letrozole 3Gemcitabine 3Cisplatin 3130-nm albumin-bound paclitaxel 3taxane 2talazoparib 2palbociclib 2abemaciclib 2Temozolomide 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Poly(ADP-ribose) Polymerase Inhibitors 2Palliative Care 2Immunoglobulin G 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fallopian Tube Neoplasms × Sutures × Clear all
NCT06024109 2026-06-02

BARHYSTER

Aesculap AG

Recruiting
132 enrolled
Gynecologic

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡